Here, we identified IRAK3 as a key inhibitor of TLR2/NFκB-mediated chronic inflammation that is negatively associated with oxidative stress, and obesity-related insulin resistance and metabolic syndrome. Here, TLR2 is linked to metabolic syndrome.